VBI Vaccines Announces Upcoming Poster Presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR Virtual Annual Meeting
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.